BIOMAT Database Logo BIOMAT Database Logo

The value and safety of nebulized aminophylline in acute bronchial asthma. 1966

G E Horton

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012138 Respiratory Therapy Care of patients with deficiencies and abnormalities associated with the cardiopulmonary system. It includes the therapeutic use of medical gases and their administrative apparatus, environmental control systems, humidification, aerosols, ventilatory support, bronchopulmonary drainage and exercise, respiratory rehabilitation, assistance with cardiopulmonary resuscitation, and maintenance of natural, artificial, and mechanical airways. Inhalation Therapy,Therapy, Inhalation,Therapy, Respiratory,Inhalation Therapies,Respiratory Therapies,Therapies, Inhalation,Therapies, Respiratory
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000628 Aminophylline A drug combination that contains THEOPHYLLINE and ethylenediamine. It is more soluble in water than theophylline but has similar pharmacologic actions. It's most common use is in bronchial asthma, but it has been investigated for several other applications. Afonilum,Aminodur,Aminophyllin,Aminophylline DF,Cardophyllin,Carine,Clonofilin,Corophyllin,Diaphyllin,Drafilyn,Duraphyllin,Eufilina,Eufilina Venosa,Euphyllin,Euphyllin Retard,Euphylline,Godafilin,Mini-Lix,Mundiphyllin,Mundiphyllin Retard,Novophyllin,Phyllocontin,Phyllotemp,Somophyllin,Tari-Dog,Theophyllamin Jenapharm,Theophyllamine,Theophyllin EDA-ratiopharm,Theophylline Ethylenediamine,Truphylline,Ethylenediamine, Theophylline,Theophyllin EDA ratiopharm,Theophyllin EDAratiopharm
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas

Related Publications

G E Horton
Nebulized fenoterol and i.v. aminophylline in acute severe asthma.
May 1987, European journal of respiratory diseases,
G E Horton
Nebulized fenoterol versus i.v. aminophylline treatment of acute severe asthma.
November 1995, The American journal of emergency medicine,
G E Horton
Nebulized fenoterol versus intravenous aminophylline treatment of acute severe asthma.
January 1998, The American journal of emergency medicine,
G E Horton
Aminophylline in bronchial asthma.
December 1967, Lancet (London, England),
G E Horton
[Action of aminophylline in acute crisis of bronchial asthma].
August 1973, Revista paulista de medicina,
G E Horton
Nebulized magnesium sulphate versus nebulized salbutamol in acute bronchial asthma: a clinical trial.
August 1998, The European respiratory journal,
G E Horton
Management of acute bronchial asthma--intravenous terbutaline or aminophylline?
March 1989, Journal of the Indian Medical Association,
G E Horton
Long-term efficacy and safety of nebulized metaproterenol solution in bronchial asthma.
November 1976, Chest,
G E Horton
Aminophylline in the treatment of bronchial asthma.
November 1999, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
G E Horton
Intravenous terbutaline and aminophylline in bronchial asthma.
April 1988, Journal of the Indian Medical Association,
Copied contents to your clipboard!